Quick Answer
Amphastar Pharmaceuticals, Inc. reported Stockholders Equity of $788.80 million for fiscal year 2025.
Amphastar Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $788.80M | +7.7% |
| 2024 | $732.30M | +14.5% |
| 2023 | $639.42M | +21.0% |
| 2022 | $528.66M | +18.7% |
| 2021 | $445.52M | +10.7% |
| 2020 | $402.31M | +5.5% |
| 2019 | $381.37M | +14.7% |
| 2018 | $332.44M | -0.4% |
| 2017 | $333.74M | +1.4% |
| 2016 | $329.25M | +11.4% |
| 2015 | $295.51M | +4.8% |
| 2014 | $281.86M | +12.1% |
| 2013 | $251.54M | +7.8% |
| 2012 | $233.44M | +12.0% |
| 2011 | $208.52M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $776.75M | +6.7% | +2.5% |
| June 30, 2025 | $757.48M | +6.2% | +0.8% |
| March 31, 2025 | $751.28M | +11.7% | +2.6% |
| December 31, 2024 | $732.30M | +14.5% | +0.6% |
| September 30, 2024 | $727.68M | +22.3% | +2.0% |
| June 30, 2024 | $713.35M | +21.1% | +6.1% |
| March 31, 2024 | $672.36M | +22.6% | +5.2% |
| December 31, 2023 | $639.42M | +21.0% | +7.4% |
- Amphastar Pharmaceuticals, Inc. showed an increase of +7.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, Amphastar Pharmaceuticals, Inc.’s stockholders equity has grown by 278.3% (from $208.52 million to $788.80 million).
- The most recent figure is from Amphastar Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: